Literature DB >> 15772130

The myogenic potency of HLH-1 reveals wide-spread developmental plasticity in early C. elegans embryos.

Tetsunari Fukushige1, Michael Krause.   

Abstract

In vertebrates, striated muscle development depends on both the expression of members of the myogenic regulatory factor family (MRFs) and on extrinsic cellular cues, including Wnt signaling. The 81 embryonically born body wall muscle cells in C. elegans are comparable to the striated muscle of vertebrates. These muscle cells all express the gene hlh-1, encoding HLH-1 (CeMyoD) which is the only MRF-related factor in the nematode. However, genetic studies have shown that body wall muscle development occurs in the absence of HLH-1 activity, making the role of this factor in nematode myogenesis unclear. By ectopically expressing hlh-1 in early blastomeres of the C. elegans embryo, we show that CeMyoD is a bona fide MRF that can convert almost all cells to a muscle-like fate, regardless of their lineage of origin. The window during which ectopic HLH-1 can function is surprisingly broad, spanning the first 3 hours of development when cell lineages are normally established and non-muscle cell fate markers begin to be expressed. We have begun to explore the maternal factors controlling zygotic hlh-1 expression. We find that the Caudal-related homeobox factor PAL-1 can activate hlh-1 in blastomeres that either lack POP-1/TCF or that have down-regulated POP-1/TCF in response to Wnt/MAP kinase signaling. The potent myogenic activity of HLH-1 highlights the remarkable developmental plasticity of early C. elegans blastomeres and reveals the evolutionary conservation of MyoD function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15772130     DOI: 10.1242/dev.01774

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  62 in total

1.  Muscle development in Ciona intestinalis requires the b-HLH myogenic regulatory factor gene Ci-MRF.

Authors:  Thomas H Meedel; Patrick Chang; Hitoyoshi Yasuo
Journal:  Dev Biol       Date:  2006-09-29       Impact factor: 3.582

2.  PHA-4/FoxA cooperates with TAM-1/TRIM to regulate cell fate restriction in the C. elegans foregut.

Authors:  Julie C Kiefer; Pliny A Smith; Susan E Mango
Journal:  Dev Biol       Date:  2006-12-02       Impact factor: 3.582

Review 3.  Combinatorial decoding of the invariant C. elegans embryonic lineage in space and time.

Authors:  Amanda L Zacharias; John Isaac Murray
Journal:  Genesis       Date:  2016-03-19       Impact factor: 2.487

Review 4.  Cell Biology of the Caenorhabditis elegans Nucleus.

Authors:  Orna Cohen-Fix; Peter Askjaer
Journal:  Genetics       Date:  2017-01       Impact factor: 4.562

5.  Myogenic conversion and transcriptional profiling of embryonic blastomeres in Caenorhabditis elegans.

Authors:  Tetsunari Fukushige; Michael Krause
Journal:  Methods       Date:  2011-10-13       Impact factor: 3.608

6.  Revealing developmental networks by comparative transcriptomics.

Authors:  Tamar Hashimshony; Itai Yanai
Journal:  Transcription       Date:  2010-07-27

Review 7.  Repression of somatic cell fate in the germline.

Authors:  Valérie J Robert; Steve Garvis; Francesca Palladino
Journal:  Cell Mol Life Sci       Date:  2015-06-05       Impact factor: 9.261

8.  The Hox transcription factor Ubx stabilizes lineage commitment by suppressing cellular plasticity in Drosophila.

Authors:  Katrin Domsch; Julie Carnesecchi; Vanessa Disela; Jana Friedrich; Nils Trost; Olga Ermakova; Maria Polychronidou; Ingrid Lohmann
Journal:  Elife       Date:  2019-05-03       Impact factor: 8.140

9.  Mechanism of chromatin segregation to the nuclear periphery in C. elegans embryos.

Authors:  Adriana Gonzalez-Sandoval; Susan M Gasser
Journal:  Worm       Date:  2016-05-31

10.  Dynamic chromatin organization during foregut development mediated by the organ selector gene PHA-4/FoxA.

Authors:  Tala H I Fakhouri; Jeff Stevenson; Andrew D Chisholm; Susan E Mango
Journal:  PLoS Genet       Date:  2010-08-12       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.